STRYKER CORP (SYK) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:SYK - US8636671013 - Common Stock
SYK Key Statistics, Chart & Performance
The current stock price of SYK is 351.47 USD. In the past month the price decreased by -4.15%. In the past year, price decreased by -2.78%.
SYK Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.11 | 217.86B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.78 | 200.77B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.32 | 141.35B | ||
| BDX | BECTON DICKINSON AND CO | 13.46 | 55.39B | ||
| IDXX | IDEXX LABORATORIES INC | 53.65 | 54.02B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.17 | 49.47B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.87 | 37.36B | ||
| RMD | RESMED INC | 24.33 | 35.16B | ||
| DXCM | DEXCOM INC | 35.68 | 25.89B | ||
| PODD | INSULET CORP | 62.2 | 20.00B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.11 | 17.82B | ||
| HOLX | HOLOGIC INC | 17.44 | 16.60B |
Related stock screener links
About SYK
Company Profile
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 53,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Company Info
STRYKER CORP
1941 Stryker Way
Portage MICHIGAN 49002 US
CEO: Kevin A. Lobo
Employees: 53000
Phone: 12693852600
STRYKER CORP / SYK FAQ
What does STRYKER CORP do?
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 53,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
What is the stock price of STRYKER CORP today?
The current stock price of SYK is 351.47 USD. The price decreased by -0.75% in the last trading session.
What is the dividend status of STRYKER CORP?
STRYKER CORP (SYK) has a dividend yield of 0.99%. The yearly dividend amount is currently 3.2.
What is the ChartMill rating of STRYKER CORP stock?
SYK has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Would investing in STRYKER CORP be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SYK.
Is STRYKER CORP (SYK) expected to grow?
The Revenue of STRYKER CORP (SYK) is expected to grow by 10.91% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is STRYKER CORP worth?
STRYKER CORP (SYK) has a market capitalization of 134.41B USD. This makes SYK a Large Cap stock.
SYK Technical Analysis
SYK Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SYK. While SYK belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
SYK Financial Highlights
Over the last trailing twelve months SYK reported a non-GAAP Earnings per Share(EPS) of 13.17. The EPS increased by 13.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.07% | ||
| ROA | 6.25% | ||
| ROE | 13.51% | ||
| Debt/Equity | 0.68 |
SYK Forecast & Estimates
36 analysts have analysed SYK and the average price target is 437.04 USD. This implies a price increase of 24.35% is expected in the next year compared to the current price of 351.47.
For the next year, analysts expect an EPS growth of 12.33% and a revenue growth 10.91% for SYK